REMODEL I/II Trials: Efficacy, Safety, and Tolerability of Remibrutinib in Patients With Relapsing Multiple SclerosisH. Wiendl,L. Airas,T. Chitnis, M. Williams,J. Nakahara,R. Bermel, A. Mann,M. Ziehn,A. Bhatt,B. Hunter,Y. Zhang,R. Karan,B. Kieseier,X. MontalbanEUROPEAN JOURNAL OF NEUROLOGY(2022)引用 0|浏览23暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要